Today’s special edition features an extended conversation between Dr. Eric Topol, Director of the Scripps Research Translational Institute, and Professor Dennis Burton, Chair of the Department of Immunology and Microbiology at Scripps Research. Listen as they talk about antibody cocktail treatments, the mystery of “longhaul” COVID-19 symptoms and how close we are to developing a coronavirus vaccine.

Transcript of today's episode
https://www.scripps.edu/covid-19/videos/topol-burton/index.html

Dr. Eric Topol’s bio
https://www.scripps.edu/faculty/topol/

Prof. Dennis Burton’s bio
https://www.scripps.edu/faculty/burton/

Efficacy of convalescent plasma
https://www.sandiegouniontribune.com/business/biotech/story/2020-08-30/hundreds-of-san-diegans-with-covid-19-have-already-been-treated-with-plasma-but-does-it-work

“COVID longhaulers”
https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/

Coronavirus vaccine Q&A with Prof. Dennis Burton
https://www.sandiegouniontribune.com/business/biotech/story/2020-07-26/q-a-an-update-on-the-race-for-a-covid-19-vaccine-scripps-research-immunologist-dennis-burton

Dr. Eric Topol on social media:
Twitter: @EricTopol
Instagram: @erictopol1

Scripps Research on social media:
Twitter, Instagram: @scrippsresearch
Facebook: @ScrippsResearchInstitute
LinkedIn: the-scripps-research-institute

Ver todos los episodios